BDM burgundy diamond mines limited

Whereas BioDiem has completed treatment in phase I/II study of...

  1. 559 Posts.
    Whereas BioDiem has completed treatment in phase I/II study of eye drug BDM-E and results were due November 07, I have been reliably informed that results are being brought forward to early October.

    Once again you need to ask the question, why bring something forward if it is not good news?

    Another source tells me that there is soon to be a capital raising at BDM, maybe to pay for further drug development after positive results (pure speculation)

    Do your own research. I do not hold.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
2.2¢
Change
-0.001(4.35%)
Mkt cap ! $31.26M
Open High Low Value Volume
2.2¢ 2.2¢ 2.2¢ $1K 45.45K

Buyers (Bids)

No. Vol. Price($)
6 489140 2.1¢
 

Sellers (Offers)

Price($) Vol. No.
2.4¢ 383415 3
View Market Depth
Last trade - 15.36pm 12/09/2025 (20 minute delay) ?
BDM (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.